| Real-world pattern of biologic use in patients with inflammatory bowel disease: treatment persistence, switching, and importance of concurrent immunosuppressive therapy C Chen, AG Hartzema, H Xiao, YJ Wei, N Chaudhry, O Ewelukwa, ... Inflammatory bowel diseases 25 (8), 1417-1427, 2019 | 133 | 2019 |
| Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD H Park, C Chen, W Wang, L Henry, RL Cook, DR Nelson Hepatology 67 (2), 492-504, 2018 | 98 | 2018 |
| Qualitative measures that assess functional disability and quality of life in ALS SL Hartmaier, T Rhodes, SF Cook, C Schlusser, C Chen, S Han, N Zach, ... Health and quality of life outcomes 20 (1), 12, 2022 | 31 | 2022 |
| New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology? AH Santos Jr, C Chen, MJ Casey, KL Womer, X Wen Nephrology Dialysis Transplantation 33 (1), 177-184, 2018 | 23 | 2018 |
| Internal validation of Medicaid Analytic eXtract (MAX) data capture for comprehensive managed care plan enrollees from 2007 to 2010 Y Li, Y Zhu, C Chen, X Wang, Y Choi, C Henriksen, AG Winterstein Pharmacoepidemiology and drug safety 27 (10), 1067-1076, 2018 | 22 | 2018 |
| Outcomes in Human Immunodeficiency Virus Infected Recipients of Heart Transplants C Chen, X Wen, A Yadav, N Belviso, S Kogut, J McCauley Clinical transplantation, e13440, 2018 | 17 | 2018 |
| Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy C Chen, A Chan, K Yap Journal of Oncology Pharmacy Practice 19 (2), 111-120, 2013 | 17 | 2013 |
| Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon C Chen, C Watson ClinicoEconomics and Outcomes Research 10, 723-730, 2018 | 12 | 2018 |
| A descriptive review of global real world evidence efforts to advance drug discovery and clinical development in amyotrophic lateral sclerosis SF Cook, T Rhodes, C Schlusser, S Han, C Chen, N Zach, V Murthy, ... Frontiers in Neurology 12, 770001, 2021 | 9 | 2021 |
| Association of HLA mismatch and MTOR inhibitor regimens with malignancy and mortality after kidney transplantation AH Santos Jr, C Chen, MA Leghrouz, EP Bueno, JJ Lee, X Wen Transplant Immunology 66, 101391, 2021 | 4 | 2021 |
| Comparative persistence of biologics in the treatment of inflammatory bowel disease: a Truven Marketscan database study C Chen, O Ewelukwa, EM Zimmermann, A Hartzema, SC Glover, ... Gastroenterology 152 (5), S594, 2017 | 4 | 2017 |
| Is fidaxomicin worth the cost? The verdict is still out! AG Hartzema, C Chen Clinical infectious diseases 58 (4), 604-605, 2014 | 4 | 2014 |
| Association between allergic conditions and COVID-19 susceptibility and outcomes C Chen, X Song, DJ Murdock, A Marcus, M Hussein, JJ Jalbert, GP Geba Annals of Allergy, Asthma & Immunology 132 (5), 637-645. e7, 2024 | 3 | 2024 |
| Outcomes of sirolimus regimens in 65-year-old and older kidney transplant recipients: a registry-based observational study AH Santos, C Chen, K Alquadan, X Wen International Urology and Nephrology 51, 2063-2072, 2019 | 3 | 2019 |
| The Epidemiology and Economic Health Burden of the College-Aged IBD Population NA Chaudhry, C Chen, A Pham, A Hartzema, SC Glover, ... Gastroenterology 154 (6), S-612-S-613, 2018 | 2 | 2018 |
| Epidemiology of myasthenia gravis in the United States Y Ye, DJ Murdock, C Chen, W Liedtke, C Knox Frontiers in Neurology 15, 1339167, 2024 | | 2024 |
| Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States W Wang, C Chen, VL Re III, SH Chang, DL Wilson, H Park Pharmacoepidemiology and drug safety 32 (10), 1142-1151, 2023 | | 2023 |
| Pharmacological treatment utilization and discontinuation before and during pregnancy in women with inflammatory bowel disease X Wang, C Chen, EM Zimmermann, JM Brown, H Xiao, A Winterstein PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 242-242, 2018 | | 2018 |
| Anti-TNF and Immunomodulator Therapy Modify the Risk of Ischemic Heart Disease in Patients with Severe Inflammatory Bowel Disease C Chen, NA Chaudhry, A Hartzema, W Wang, EM Zimmermann Gastroenterology 154 (6), S-374, 2018 | | 2018 |
| The Risk of Serious Infections in Patients with Inflammatory Bowel Diseases Treated with Mono-and Combination Therapy C Chen, NA Chaudhry, A Hartzema, LK Mramba, EM Zimmermann Gastroenterology 154 (6), S-358, 2018 | | 2018 |
